Entera Bio Ltd. (ENTX)
undefined
undefined%
At close: undefined
2.85
5.95%
After-hours Jan 06, 2025, 07:56 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Net Income -8.89M -13.07M -12.19M -9.98M -10.79M -10.30M -11.20M -1.20M -4.28M
Depreciation & Amortization 56.00K 64.00K 53.00K 225.00K 238.00K 54.00K 43.00K 35.00K 28.00K
Stock-Based Compensation 1.69M 2.25M 1.86M 901.00K 1.48M 1.23M 4.88M 1.49M 366.00K
Other Working Capital -507.00K -1.62M 1.33M -109.00K 42.00K 225.00K 366.00K 651.00K -410.00K
Other Non-Cash Items n/a -78.00K 18.00K -1.18M -569.00K -232.00K 1.16M -3.84M 576.00K
Deferred Income Tax 29.00K 174.00K -217.00K -33.00K 33.00K -41.00K -324.00K 22.00K n/a
Change in Working Capital -195.00K -1.83M 1.41M -351.00K 691.00K -506.00K 909.00K 353.00K -183.00K
Operating Cash Flow -7.31M -12.50M -9.06M -10.42M -8.92M -9.80M -4.53M -3.14M -3.50M
Capital Expenditures -17.00K -47.00K -17.00K -53.00K -40.00K -68.00K -51.00K -41.00K -54.00K
Acquisitions n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments n/a n/a n/a n/a n/a -4.00M n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies n/a -55.00K n/a -33.00K 3.99M -4.00M 1.05M -1.07M n/a
Investing Cash Flow -17.00K -102.00K -17.00K -86.00K 3.95M -4.07M 1.00M -1.12M -54.00K
Debt Repayment n/a n/a n/a -136.00K -114.00K n/a -980.00K 7.22M 2.00M
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies -580.00K 13.00K 3.58M 204.00K 238.00K n/a 12.09M n/a 2.46M
Financial Cash Flow 6.04M 13.00K 25.38M 3.92M 12.65M 9.62M 11.11M 7.22M 4.46M
Net Cash Flow -1.29M -12.59M 16.30M -6.59M 7.68M -4.24M 7.58M 2.96M 915.00K
Free Cash Flow -7.33M -12.55M -9.08M -10.48M -8.96M -9.86M -4.58M -3.18M -3.55M